182 related articles for article (PubMed ID: 38599063)
21. Cuproptosis and cuproptosis-related genes: Emerging potential therapeutic targets in breast cancer.
Liu X; Luo B; Wu X; Tang Z
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189013. PubMed ID: 37918452
[TBL] [Abstract][Full Text] [Related]
22. Cuproptosis: unveiling a new frontier in cancer biology and therapeutics.
Feng Y; Yang Z; Wang J; Zhao H
Cell Commun Signal; 2024 May; 22(1):249. PubMed ID: 38693584
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of cuproptosis in immune response and prognosis of osteosarcoma.
Li M; Song Q; Bai Y; Hua F; Wu T; Liu J
Front Pharmacol; 2022; 13():992431. PubMed ID: 36263140
[TBL] [Abstract][Full Text] [Related]
24. Current and Future of "Turn-On" Based Small-Molecule Copper Probes for Cuproptosis.
Peng TE; Qiu F; Qu Y; Yu C; Cheng X; Li L
ChemistryOpen; 2023 Sep; 12(9):e202300078. PubMed ID: 37705070
[TBL] [Abstract][Full Text] [Related]
25. Cuproptosis: emerging biomarkers and potential therapeutics in cancers.
Wang M; Zheng L; Ma S; Lin R; Li J; Yang S
Front Oncol; 2023; 13():1288504. PubMed ID: 38023234
[TBL] [Abstract][Full Text] [Related]
26. Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance.
Wang Y; Chen Y; Zhang J; Yang Y; Fleishman JS; Wang Y; Wang J; Chen J; Li Y; Wang H
Drug Resist Updat; 2024 Jan; 72():101018. PubMed ID: 37979442
[TBL] [Abstract][Full Text] [Related]
27. From ferroptosis to cuproptosis, and calcicoptosis, to find more novel metals-mediated distinct form of regulated cell death.
Gu J; Guo C; Ruan J; Li K; Zhou Y; Gong X; Shi H
Apoptosis; 2024 Jun; 29(5-6):586-604. PubMed ID: 38324163
[TBL] [Abstract][Full Text] [Related]
28. Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials.
Wang J; Li J; Liu J; Chan KY; Lee HS; Lin KN; Wang CC; Lau TS
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339263
[TBL] [Abstract][Full Text] [Related]
29. Research progress in cuproptosis in liver cancer.
Chen L; Liu D; Tan Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Sept 28; 48(9):1368-1376. PubMed ID: 38044648
[TBL] [Abstract][Full Text] [Related]
30. Copper Deposition in Polydopamine Nanostructure to Promote Cuproptosis by Catalytically Inhibiting Copper Exporters of Tumor Cells for Cancer Immunotherapy.
Chang J; Yin W; Zhi H; Chen S; Sun J; Zhao Y; Huang L; Xue L; Zhang X; Zhang T; Dong H; Li Y
Small; 2024 Feb; ():e2308565. PubMed ID: 38339770
[TBL] [Abstract][Full Text] [Related]
31. Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy.
Lu X; Chen X; Lin C; Yi Y; Zhao S; Zhu B; Deng W; Wang X; Xie Z; Rao S; Ni Z; You T; Li L; Huang Y; Xue X; Yu Y; Sun W; Shen X
Adv Sci (Weinh); 2024 May; 11(18):e2309984. PubMed ID: 38430531
[TBL] [Abstract][Full Text] [Related]
32. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease.
Wang D; Tian Z; Zhang P; Zhen L; Meng Q; Sun B; Xu X; Jia T; Li S
Biomed Pharmacother; 2023 Jul; 163():114830. PubMed ID: 37150036
[TBL] [Abstract][Full Text] [Related]
33. Cuproptosis: Unraveling the Mechanisms of Copper-Induced Cell Death and Its Implication in Cancer Therapy.
Springer C; Humayun D; Skouta R
Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339398
[TBL] [Abstract][Full Text] [Related]
34. The Tao of copper metabolism: from physiology to pathology.
Gao S; Zhou M; Tang Z
Curr Med Chem; 2023 Sep; ():. PubMed ID: 37718523
[TBL] [Abstract][Full Text] [Related]
35. Contribution of cuproptosis and Cu metabolism-associated genes to chronic obstructive pulmonary disease.
Qi W; Liu L; Zeng Q; Zhou Z; Chen D; He B; Gong S; Gao L; Wang X; Xiong J; Cai D; Yu S; Zhao L
J Cell Mol Med; 2023 Dec; 27(24):4034-4044. PubMed ID: 37801050
[TBL] [Abstract][Full Text] [Related]
36. Cuproptosis: Harnessing Transition Metal for Cancer Therapy.
Wang W; Mo W; Hang Z; Huang Y; Yi H; Sun Z; Lei A
ACS Nano; 2023 Oct; 17(20):19581-19599. PubMed ID: 37820312
[TBL] [Abstract][Full Text] [Related]
37. Emerging insights into cuproptosis and copper metabolism: implications for age-related diseases and potential therapeutic strategies.
Fan H; Wang K; Zhao X; Song B; Yao T; Liu T; Gao G; Lu W; Liu C
Front Aging Neurosci; 2024; 16():1335122. PubMed ID: 38715962
[TBL] [Abstract][Full Text] [Related]
38. The mechanism of copper transporters in ovarian cancer cells and the prospect of cuproptosis.
Guo J; Sun Y; Liu G
J Inorg Biochem; 2023 Oct; 247():112324. PubMed ID: 37481825
[TBL] [Abstract][Full Text] [Related]
39. Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies.
Bian C; Zheng Z; Su J; Chang S; Yu H; Bao J; Xin Y; Jiang X
Front Pharmacol; 2023; 14():1271613. PubMed ID: 37767404
[TBL] [Abstract][Full Text] [Related]
40. Elucidating cuproptosis in metabolic dysfunction-associated steatotic liver disease.
Li Y; Qi P; Song SY; Wang Y; Wang H; Cao P; Liu Y; Wang Y
Biomed Pharmacother; 2024 May; 174():116585. PubMed ID: 38615611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
